Advanced Oncotherapy plc (AIM:AVO) announced a prospective recapitalisation and funding plan to raise up to c.£110 million. The prospective plan comprises three elements: (i) a debt to equity conversion (the "Debt to Equity Swap"); (ii) the Company receiving a new interest-bearing secured loan; and (iii) an equity fundraising (the "Equity Fundraising") (together the "Prospective Recapitalisation Plan"). As at the date of this announcement the Prospective Recapitalisation Plan, which is still at an early stage, is subject to, amongst other things, a number of conditions being satisfied and various documentation being negotiated, agreed and entered into.

Whilst the board of Advanced Oncotherapy is hopeful of a satisfactory outcome, certain elements of the Prospective Recapitalisation Plan, in particular the Equity Fundraising, remain at an early stage and there can be no certainty that it will proceed nor to the terms or timing thereof.